Phathom Pharmaceuticals (PHAT) Change in Cash (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Change in Cash for 9 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Cash rose 102.51% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $32.9 million (up 125.98% YoY), while the FY2025 annual figure was -$167.3 million, down 98.85% from the prior year.
• Change in Cash declined to $1.6 million in Q2 2026 per PHAT's latest filing, from $50.9 million in the prior quarter.
• Across five years, Change in Cash topped out at $167.7 million in Q4 2023 and bottomed at -$84.9 million in Q1 2025.
• Historically, Change in Cash has averaged $106833.3 across 5 years, with a median of -$20.1 million in 2023.
• On a YoY basis, Change in Cash climbed as much as 504.61% in 2023 and fell as far as 211.16% in 2023.
• Phathom Pharmaceuticals' Change in Cash stood at -$41.5 million in 2022, then surged by 504.61% to $167.7 million in 2023, then sank by 122.31% to -$37.4 million in 2024, then jumped by 86.14% to -$5.2 million in 2025, then surged by 130.41% to $1.6 million in 2026.
• Business Quant data shows PHAT's Change in Cash at $1.6 million in Q2 2026, $50.9 million in Q1 2026, and -$5.2 million in Q4 2025.